Market Overview

Sage Therapeutics (NASDAQ: SAGE)

123.83 +2.39 (1.97%)

Analyst Ratings

DateResearch FirmActionCurrentPT
10/11/18Morgan StanleyMaintainsOverweight230.0
8/06/18PiperJaffrayInitiates Coverage OnOverweight206.0
7/13/18Morgan StanleyMaintainsOverweight228.0
6/13/18Canaccord GenuityMaintainsBuy220.0
6/06/18Ladenburg ThalmannInitiates Coverage OnBuy230.0
2/26/18Morgan StanleyInitiates Coverage OnOverweight225.0
11/17/17BMO CapitalMaintainsOutperform112.0
11/16/17Bank of AmericaMaintainsBuy101.0
11/13/17Canaccord GenuityMaintainsBuy140.0
11/10/17Chardan CapitalUpgradesBuy

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter